ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib

Autor: Vivona, Douglas, Bueno, Carolina T., Lima, Luciene T., Hirata, Rosario D.C., Hirata, Mario H., Luchessi, André D., Zanichelli, Maria A., Chiattone, Carlos S., Guerra-Shinohara, Elvira M.
Zdroj: In Blood Cells, Molecules and Diseases 15 February 2012 48(2):132-136
Databáze: ScienceDirect